Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Kerry Flom. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Kerry Flom har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:CPHD / Cepheid | EVP, Regulatory Affairs | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Kerry Flom. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Kerry Flom som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2015-08-11 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −2 202 | 0 | −100,00 | 51,39 | −113 161 | |
2015-08-11 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −9 584 | 4 792 | −66,67 | |||
2015-08-11 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −12 890 | 28 360 | −31,25 | |||
2015-08-11 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −29 531 | 22 969 | −56,25 | |||
2015-08-11 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −4 220 | 4 219 | −50,01 | |||
2015-08-11 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −4 267 | 0 | −100,00 | |||
2015-08-11 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −11 330 | 2 202 | −83,73 | 51,85 | −587 458 | 114 173 |
2015-08-11 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −54 008 | 67 540 | −44,43 | 51,10 | −2 759 798 | 3 451 280 |
2015-08-11 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 9 584 | 57 956 | 19,81 | 35,48 | 340 040 | 2 056 279 |
2015-08-11 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 12 890 | 45 066 | 40,06 | 45,84 | 590 878 | 2 065 825 |
2015-08-11 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 29 531 | 15 535 | −211,00 | 38,66 | 1 141 668 | 600 583 |
2015-08-11 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 4 220 | 11 315 | 59,48 | 35,72 | 150 738 | 404 172 |
2015-08-11 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 4 267 | 7 048 | 153,43 | 31,48 | 134 346 | 221 906 |
2015-07-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −365 | 2 560 | −12,48 | ||||
2015-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −114 | 37 048 | −0,31 | 55,71 | −6 351 | 2 063 944 | |
2015-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 365 | 37 162 | 0,99 | ||||
2015-07-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −156 | 469 | −24,96 | ||||
2015-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −49 | 36 797 | −0,13 | 56,26 | −2 757 | 2 070 199 | |
2015-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 156 | 36 846 | 0,43 | ||||
2015-07-23 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −281 | 3 094 | −8,33 | ||||
2015-07-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −88 | 36 690 | −0,24 | 62,93 | −5 538 | 2 308 902 | |
2015-07-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 281 | 36 778 | 0,77 | ||||
2015-07-06 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −2 397 | 4 794 | −33,33 | ||||
2015-07-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −746 | 36 497 | −2,00 | 58,04 | −43 298 | 2 118 286 | |
2015-07-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 2 397 | 37 243 | 6,88 | ||||
2015-05-01 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −366 | 2 925 | −11,12 | ||||
2015-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −114 | 34 846 | −0,33 | 56,71 | −6 465 | 1 976 117 | |
2015-05-01 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 366 | 34 960 | 1,06 | ||||
2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
A - Award | 30 000 | 34 594 | 653,03 | ||||
2015-04-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −237 | 0 | −100,00 | ||||
2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −74 | 4 594 | −1,59 | 58,97 | −4 364 | 270 908 | |
2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 237 | 4 668 | 5,35 | ||||
2015-04-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −157 | 625 | −20,08 | ||||
2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −49 | 4 431 | −1,09 | 58,97 | −2 890 | 261 296 | |
2015-04-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 157 | 4 480 | 3,63 | ||||
2015-04-23 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −1 125 | 3 375 | −25,00 | ||||
2015-04-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −350 | 4 323 | −7,49 | 53,92 | −18 872 | 233 096 | |
2015-04-23 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 125 | 4 673 | 31,71 | ||||
2015-04-06 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −2 397 | 7 191 | −25,00 | ||||
2015-04-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −746 | 3 548 | −17,37 | 56,81 | −42 380 | 201 562 | |
2015-04-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 2 397 | 4 294 | 126,36 | ||||
2015-02-02 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −365 | 3 291 | −9,98 | ||||
2015-02-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −114 | 1 897 | −5,67 | 54,09 | −6 166 | 102 609 | |
2015-02-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 365 | 2 011 | 22,17 | ||||
2015-01-27 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −237 | 237 | −50,00 | ||||
2015-01-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −74 | 1 646 | −4,30 | 55,02 | −4 071 | 90 563 | |
2015-01-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 237 | 1 720 | 15,98 | ||||
2015-01-27 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −156 | 782 | −16,63 | ||||
2015-01-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −49 | 1 483 | −3,20 | 55,02 | −2 696 | 81 595 | |
2015-01-27 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 156 | 1 532 | 11,34 | ||||
2015-01-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −700 | 1 376 | −33,72 | 54,93 | −38 453 | 75 588 |
2015-01-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −807 | 2 076 | −27,99 | 53,88 | −43 482 | 111 856 |
2015-01-06 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −7 187 | 14 376 | −33,33 | |||
2015-01-06 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −2 397 | 9 588 | −20,00 | ||||
2015-01-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −400 | 2 883 | −12,18 | 54,77 | −21 907 | 157 895 |
2015-01-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −6 787 | 3 283 | −67,40 | 54,14 | −367 481 | 177 758 |
2015-01-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 7 187 | 10 070 | 249,29 | 35,48 | 254 995 | 357 284 |
2015-01-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −890 | 2 883 | −23,59 | 54,12 | −48 167 | 156 028 | |
2015-01-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 2 397 | 3 773 | 174,20 | ||||
2014-10-31 |
|
4 | CPHD |
CEPHEID
Non-qualified option (right to buy) |
M - Exercise | X | −2 812 | 8 439 | −24,99 | |||
2014-10-31 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −4 265 | 4 267 | −49,99 | |||
2014-10-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −366 | 3 656 | −9,10 | ||||
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −1 490 | 1 376 | −51,99 | 51,73 | −77 078 | 71 180 |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 587 | 2 866 | −66,09 | 51,26 | −286 390 | 146 911 |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 2 812 | 8 453 | 49,85 | 35,72 | 100 445 | 301 941 |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 4 265 | 5 641 | 309,96 | 31,48 | 134 284 | 177 607 |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −172 | 1 376 | −11,11 | 51,90 | −8 927 | 71 414 | |
2014-10-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 366 | 1 548 | 30,96 | ||||
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −125 | 1 182 | −9,56 | 51,48 | −6 435 | 60 852 |
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −82 | 1 307 | −5,90 | 49,98 | −4 098 | 65 324 |
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −112 | 1 389 | −7,46 | 50,08 | −5 609 | 69 561 | |
2014-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −237 | 474 | −33,33 | ||||
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 237 | 1 501 | 18,75 | ||||
2014-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −156 | 938 | −14,26 | ||||
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −74 | 1 264 | −5,53 | 50,08 | −3 706 | 63 301 | |
2014-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 156 | 1 338 | 13,20 | ||||
2014-10-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −300 | 1 182 | −20,24 | 44,83 | −13 450 | 52 991 |
2014-10-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −971 | 1 482 | −39,58 | 44,43 | −43 141 | 65 845 |
2014-10-06 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −2 397 | 11 985 | −16,67 | ||||
2014-10-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −1 126 | 2 453 | −31,46 | 43,71 | −49 217 | 107 221 | |
2014-10-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 2 397 | 3 579 | 202,79 | ||||
2014-07-31 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −365 | 4 022 | −8,32 | ||||
2014-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −172 | 1 182 | −12,70 | 39,50 | −6 794 | 46 689 | |
2014-07-31 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 365 | 1 354 | 36,91 | ||||
2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −125 | 989 | −11,22 | 39,53 | −4 941 | 39 095 |
2014-07-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −237 | 711 | −25,00 | ||||
2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −112 | 1 114 | −9,14 | 39,47 | −4 421 | 43 970 | |
2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 237 | 1 226 | 23,96 | ||||
2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −82 | 989 | −7,66 | 40,18 | −3 295 | 39 738 |
2014-07-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −156 | 1 094 | −12,48 | ||||
2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −74 | 1 071 | −6,46 | 40,55 | −3 001 | 43 429 | |
2014-07-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 156 | 1 145 | 15,77 | ||||
2014-07-15 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −2 812 | 11 251 | −20,00 | |||
2014-07-15 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −2 812 | 989 | −73,98 | 49,72 | −139 813 | 49 173 |
2014-07-15 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 2 812 | 3 801 | 284,33 | 35,72 | 100 445 | 135 772 |
2014-07-07 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −1 282 | 989 | −56,45 | 48,97 | −62 779 | 48 431 |
2014-07-07 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −2 397 | 14 382 | −14,29 | ||||
2014-07-07 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −1 115 | 2 271 | −32,93 | 48,62 | −54 211 | 110 416 | |
2014-07-07 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 2 397 | 3 386 | 242,37 | ||||
2014-05-29 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −3 659 | 8 532 | −30,01 | |||
2014-05-29 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −3 659 | 989 | −78,72 | 45,49 | −166 448 | 44 990 |
2014-05-29 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 3 659 | 4 648 | 369,97 | 31,48 | 115 204 | 146 342 |
2014-05-29 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (Right to Buy) |
M - Exercise | X | −606 | 12 191 | −4,74 | |||
2014-05-29 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −606 | 989 | −37,99 | 45,49 | −27 567 | 44 990 |
2014-05-29 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 606 | 1 595 | 61,27 | 31,48 | 19 080 | 50 219 |
2014-04-30 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −1 463 | 4 387 | −25,01 | ||||
2014-04-30 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −2 500 | 0 | −100,00 | |||
2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −474 | 989 | −32,40 | 42,14 | −19 974 | 41 676 | |
2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 1 463 | 1 463 | |||||
2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −2 500 | 0 | −100,00 | 42,39 | −105 981 | |
2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 2 500 | 2 500 | 20,47 | 51 175 | 51 175 | |
2014-04-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −160 | 0 | −100,00 | 42,20 | −6 752 | |
2014-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −237 | 948 | −20,00 | ||||
2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −106 | 160 | −39,85 | 43,39 | −4 599 | 6 942 |
2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −77 | 266 | −22,45 | 42,02 | −3 236 | 11 177 | |
2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 237 | 343 | 223,58 | ||||
2014-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −157 | 1 250 | −11,16 | ||||
2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −51 | 106 | −32,48 | 43,55 | −2 221 | 4 616 | |
2014-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 157 | 157 | |||||
2014-04-25 | 3/A | CPHD |
CEPHEID
Common Stock |
0 | ||||||||
2014-04-23 |
|
4 | CPHD |
CEPHEID
Non-Qualified Stock Option (right to buy) |
A - Award | 41 250 | 41 250 | |||||
2014-04-23 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
A - Award | 4 500 | 4 500 | |||||
2014-04-07 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −200 | 20 000 | −0,99 | 52,32 | −10 463 | 1 046 300 |
2014-04-07 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −1 421 | 20 200 | −6,57 | 51,44 | −73 102 | 1 039 175 |
2014-04-03 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −2 397 | 16 779 | −12,50 | ||||
2014-04-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −776 | 21 621 | −3,46 | 52,79 | −40 965 | 1 141 373 | |
2014-04-03 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 2 397 | 22 397 | 11,98 | ||||
2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −100 | 20 000 | −0,50 | 48,13 | −4 813 | 962 600 |
2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −165 | 20 100 | −0,81 | 47,32 | −7 808 | 951 132 |
2014-01-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −237 | 1 185 | −16,67 | ||||
2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −77 | 20 265 | −0,38 | 48,11 | −3 704 | 974 949 | |
2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 237 | 20 342 | 1,18 | ||||
2014-01-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −156 | 1 407 | −9,98 | ||||
2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −51 | 20 105 | −0,25 | 48,11 | −2 454 | 967 252 | |
2014-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 156 | 20 156 | 0,78 | ||||
2014-01-21 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (right to buy) |
M - Exercise | X | −7 187 | 21 563 | −25,00 | |||
2014-01-21 |
|
4 | CPHD |
CEPHEID
Non-qualified Stock Option (right to buy) |
M - Exercise | X | −8 437 | 14 063 | −37,50 | |||
2014-01-21 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −7 187 | 20 000 | −26,44 | 49,48 | −355 613 | 989 600 |
2014-01-21 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 7 187 | 27 187 | 35,94 | 35,48 | 254 995 | 964 595 |
2014-01-21 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −8 437 | 20 000 | −29,67 | 49,72 | −419 488 | 994 400 |
2014-01-21 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 8 437 | 28 437 | 42,18 | 35,72 | 301 370 | 1 015 770 |
2014-01-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −6 357 | 20 000 | −24,12 | 45,66 | −290 244 | 913 148 |
2014-01-06 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −9 574 | 19 176 | −33,30 | ||||
2014-01-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −3 217 | 26 357 | −10,88 | 45,86 | −147 532 | 1 208 732 | |
2014-01-06 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 9 574 | 29 574 | 47,87 | ||||
2013-12-24 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −100 | 20 000 | −0,50 | 47,15 | −4 715 | 943 000 |
2013-12-24 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −9 900 | 20 100 | −33,00 | 46,50 | −460 357 | 934 664 |
2013-12-24 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2013-12-24 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 10 000 | 30 000 | 50,00 | ||||
2013-12-02 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −21 328 | 12 797 | −62,50 | |||
2013-12-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −21 328 | 20 000 | −51,61 | 45,49 | −970 211 | 909 800 |
2013-12-02 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 21 328 | 41 328 | 106,64 | 31,48 | 671 512 | 1 301 212 |
2013-10-30 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −2 500 | 2 500 | −50,00 | |||
2013-10-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −2 500 | 20 000 | −11,11 | 40,52 | −101 289 | 810 312 |
2013-10-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 2 500 | 22 500 | 12,50 | 20,47 | 51 175 | 460 575 |
2013-10-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −160 | 20 000 | −0,79 | 40,25 | −6 440 | 805 000 |
2013-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −237 | 1 422 | −14,29 | ||||
2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −77 | 20 160 | −0,38 | 40,48 | −3 117 | 816 077 | |
2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 237 | 20 237 | 1,18 | ||||
2013-10-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −156 | 1 563 | −9,08 | ||||
2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −55 | 20 000 | −0,27 | 40,26 | −2 214 | 805 200 | |
2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 156 | 20 055 | 0,78 | ||||
2013-10-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −101 | 19 899 | −0,50 | 39,79 | −4 019 | 791 867 |
2013-07-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −160 | 20 000 | −0,79 | 34,37 | −5 499 | 687 400 |
2013-07-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −237 | 1 659 | −12,50 | ||||
2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −77 | 20 160 | −0,38 | 34,53 | −2 659 | 696 125 | |
2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 237 | 20 237 | 1,18 | ||||
2013-07-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −156 | 1 719 | −8,32 | ||||
2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −100 | 20 000 | −0,50 | 33,96 | −3 396 | 679 200 |
2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −5 | 20 100 | −0,02 | 33,95 | −170 | 682 395 |
2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −51 | 20 105 | −0,25 | 33,80 | −1 724 | 679 549 | |
2013-07-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 156 | 20 156 | 0,78 | ||||
2013-05-14 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −2 500 | 5 000 | −33,33 | |||
2013-05-14 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −3 750 | 0 | −100,00 | |||
2013-05-14 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −6 832 | 20 000 | −25,46 | 39,76 | −271 646 | 795 216 |
2013-05-14 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 2 500 | 26 832 | 10,27 | 20,47 | 51 175 | 549 251 |
2013-05-14 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 3 750 | 24 332 | 18,22 | 8,43 | 31 612 | 205 119 |
2013-05-01 |
|
4 | CPHD |
CEPHEID
Non-Qualified Stock Option (right to buy) |
A - Award | 52 500 | 52 500 | |||||
2013-05-01 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
A - Award | 5 850 | 5 850 | |||||
2013-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −237 | 1 896 | −11,11 | ||||
2013-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −77 | 20 582 | −0,37 | 38,42 | −2 958 | 790 760 | |
2013-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 237 | 20 659 | 1,16 | ||||
2013-04-25 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −625 | 1 875 | −25,00 | ||||
2013-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −203 | 20 422 | −0,98 | 37,95 | −7 704 | 775 015 | |
2013-04-25 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 625 | 20 625 | 3,12 | ||||
2013-01-30 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −147 | 20 000 | −0,73 | 37,31 | −5 485 | 746 200 |
2013-01-30 |
|
4/A | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −2 500 | 7 500 | −25,00 | |||
2013-01-30 |
|
4/A | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −3 750 | 3 750 | −50,00 | |||
2013-01-30 |
|
4/A | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 2 500 | 26 250 | 10,53 | 20,47 | 51 175 | 537 338 |
2013-01-30 |
|
4/A | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 3 750 | 23 750 | 18,75 | 8,43 | 31 612 | 200 212 |
2013-01-28 |
|
4 | CPHD |
CEPHEID
Restricted Stock Units |
M - Exercise | −237 | 2 133 | −10,00 | ||||
2013-01-28 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
M - Exercise | X | −6 250 | 27 875 | −18,32 | |||
2013-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
F - Taxes | −90 | 20 147 | −0,44 | 37,83 | −3 405 | 762 161 | |
2013-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | 237 | 20 237 | 1,18 | ||||
2013-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
S - Sale | X | −6 250 | 20 000 | −23,81 | 38,00 | −237 500 | 760 000 |
2013-01-28 |
|
4 | CPHD |
CEPHEID
Common Stock |
M - Exercise | X | 6 250 | 26 250 | 31,25 | 31,48 | 196 781 | 826 481 |
2013-01-03 |
|
4 | CPHD |
CEPHEID
Non-qualified stock option (right to buy) |
A - Award | 28 750 | 28 750 | |||||
2013-01-03 |
|
4 | CPHD |
CEPHEID
Restricted stock units |
A - Award | 28 750 | 28 750 | |||||
2013-01-03 | 3 | CPHD |
CEPHEID
Common Stock |
20 000 |